Search - tctmd.com

Displaying 301 - 320 of 1120

Sort: Relevancy | Date

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

Rationale for and Design of GALILEO

Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja

October 31, 2016

Presentation TCT 2016

EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI

Presenter: Joseph A. Hill, Steven P. Marso, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicenter Trial

Presenter: Stephan Baldus, Allan Schwartz, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Presenter: Zahid Amin, Jacqueline Saw, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

Presentation TCT 2016

Structural Intervention IV: LAA Closure, HOCM, Paravalvular Leak

Presenter: Srihari S. Naidu, Adnan K. Chhatriwalla

October 31, 2016

Presentation TCT 2016

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

TCT 628: Very Long-Term (Up To 23 Years) Follow-Up After Successful Mitral Balloon Valvuloplasty In A Large Series Of Patients With Rheumatic Mitral Stenosis

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

Presenter: Michael J. Lim, Payam Dehghani

October 31, 2016

Presentation TCT 2016

TCT 626: Validating a Prediction Modeling Tool for LVOT obstruction After Transcatheter Mitral Valve Replacement

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

TCT 627: Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort

Presenter: Brij Maini, James E. Muller

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Presenter: Michael J. Lim, Molly Szerlip

October 31, 2016

Presentation TCT 2016

Editorial Perspective: Embolic Protection in TAVR Intervention

Presenter: Josep Rodés-Cabau

October 31, 2016

Presentation TCT 2016

Severe Asymptomatic AS

Presenter: Jean-Claude Laborde, Wilson Y. Szeto, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in a Elderly Comorbid Patient

Presenter: Maurice Buchbinder, Horst Sievert, Caterina Gandolfo

October 31, 2016

Presentation TCT 2016

Transapical OffPump Mitral Valve Repair in Patient With Severe Degenerative Mitral Valve Regurgitation After Two Renal Transplants

Presenter: Danny Dvir, Marco Moscarelli, Krzysztof Wrobel

October 31, 2016

Advertisement

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Rationale for and Design of GALILEO

EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicenter Trial

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Structural Intervention IV: LAA Closure, HOCM, Paravalvular Leak

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated with Hypertrophic Cardiomyopathy

TCT 628: Very Long-Term (Up To 23 Years) Follow-Up After Successful Mitral Balloon Valvuloplasty In A Large Series Of Patients With Rheumatic Mitral Stenosis

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation

TCT 626: Validating a Prediction Modeling Tool for LVOT obstruction After Transcatheter Mitral Valve Replacement

TCT 627: Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Editorial Perspective: Embolic Protection in TAVR Intervention

Severe Asymptomatic AS

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in a Elderly Comorbid Patient

Transapical OffPump Mitral Valve Repair in Patient With Severe Degenerative Mitral Valve Regurgitation After Two Renal Transplants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content